Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 2
1971 1
1975 2
1976 3
1977 4
1978 1
1979 2
1980 4
1981 2
1982 3
1984 3
1985 1
1988 1
1990 2
1991 2
2023 1
2024 3
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

41 results

Results by year

Filters applied: . Clear all
Page 1
Comprehensive genomic profiling by liquid biopsy captures tumor heterogeneity and identifies cancer vulnerabilities in patients with RAS/BRAFV600E wild-type metastatic colorectal cancer in the CAPRI 2-GOIM trial.
Ciardiello D, Boscolo Bielo L, Napolitano S, Martinelli E, Troiani T, Nicastro A, Latiano TP, Parente P, Maiello E, Avallone A, Normanno N, Pisconti S, Nisi C, Bordonaro R, Russo AE, Tamburini E, Toma I, Lotesoriere C, Vallarelli S, Zampino MG, Fazio N, Curigliano G, De Vita F, Ciardiello F, Martini G; CAPRI-2 GOIM study group. Ciardiello D, et al. Among authors: nisi c. Ann Oncol. 2024 Dec;35(12):1105-1115. doi: 10.1016/j.annonc.2024.08.2334. Epub 2024 Aug 29. Ann Oncol. 2024. PMID: 39214459
Comprehensive genomic profiling by liquid biopsy portrays metastatic colorectal cancer mutational landscape to predict antitumor efficacy of FOLFIRI plus cetuximab in the CAPRI-2 GOIM trial.
Ciardiello D, Boscolo Bielo L, Napolitano S, Latiano TP, De Stefano A, Tamburini E, Toma I, Bordonaro R, Russo AE, Pisconti S, Nisi C, Lotesoriere C, Vallarelli S, Lonardi S, Iacono D, Cremolini C, Tortora G, Tagliaferri P, Pietrantonio F, Rosati G, Lucenti A, Scartozzi M, Brunetti O, Cinieri S, Zampino MG, Zaniboni A, Berardi R, Paoletti G, Febbraro A, Martinelli E, Troiani T, Cioli E, Normanno N, Di Maio M, Parente P, Fazio N, Curigliano G, De Vita F, Avallone A, Maiello E, Ciardiello F, Martini G. Ciardiello D, et al. Among authors: nisi c. ESMO Open. 2025 Apr;10(4):104511. doi: 10.1016/j.esmoop.2025.104511. Epub 2025 Mar 18. ESMO Open. 2025. PMID: 40107157 Free PMC article. Clinical Trial.
The molecular tumor board as a step in cancer patient management: a southern Italian experience.
Tommasi S, Maurmo L, Rizzo A, Carella C, Ranieri G, De Summa S, Mannavola F, Chiurì VE, Guida M, Nisi C, Montrone M, Giotta F, Patruno M, Lacalamita R, Pilato B, Zito FA, Fucci L, Coppola CA, Ditonno P, Nardulli P, Quaresmini D, Strippoli S. Tommasi S, et al. Among authors: nisi c. Front Med (Lausanne). 2024 Sep 11;11:1432628. doi: 10.3389/fmed.2024.1432628. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39323465 Free PMC article.
Integrating tissue and liquid biopsy comprehensive genomic profiling to predict efficacy of anti-EGFR therapies in metastatic colorectal cancer: Findings from the CAPRI-2 GOIM study.
Ciardiello D, Boscolo Bielo L, Napolitano S, Cioli E, Latiano TP, De Stefano A, Tamburini E, Ramundo M, Bordonaro R, Russo AE, Pisconti S, Nisi C, Lotesoriere C, Vallarelli S, Lonardi S, Barruca V, Cremolini C, Tortora G, Tagliaferri P, Pietrantonio F, Rosati G, Lucenti A, Scartozzi M, Brunetti O, Zampino MG, Zaniboni A, Berardi R, Paoletti G, Febbraro A, Martinelli E, Troiani T, Normanno N, Parente P, Fazio N, Curigliano G, De Vita F, Avallone A, Maiello E, Ciardiello F, Martini G. Ciardiello D, et al. Among authors: nisi c. Eur J Cancer. 2025 Aug 26;226:115642. doi: 10.1016/j.ejca.2025.115642. Epub 2025 Jul 12. Eur J Cancer. 2025. PMID: 40669385 Clinical Trial.
Comprehensive genomic profiling by liquid biopsy in refractory metastatic colorectal cancer patients who are candidate for anti-EGFR rechallenge therapy: findings from the CAVE-2 GOIM trial.
Ciardiello D, Boscolo Bielo L, Pietrantonio F, Martini G, Troiani T, Martinelli E, Natangelo S, Bosco MF, Pisconti S, Nisi C, Tortora G, Salvatore L, Sartore-Bianchi A, Siena S, Blasi L, Messina M, Ongaro E, Zaniboni A, Pinto C, Antonuzzo L, Avallone A, Normanno N, Santabarbara G, Zampino MG, Berardi R, Cogoni AA, Leo S, Lotesoriere C, Latiano TP, Maiello E, Fazio N, Curigliano G, Bordonaro R, De Vita F, Ciardiello F, Napolitano S. Ciardiello D, et al. Among authors: nisi c. ESMO Open. 2025 Jul;10(7):105491. doi: 10.1016/j.esmoop.2025.105491. Epub 2025 Jun 23. ESMO Open. 2025. PMID: 40555076 Free PMC article. Clinical Trial.
Oncological Treatment Adverse Reaction Prediction: Development and Initial Validation of a Pharmacogenetic Model in Non-Small-Cell Lung Cancer Patients.
Cafiero C, Palmirotta R, Martinelli C, Micera A, Giacò L, Persiani F, Morrione A, Pastore C, Nisi C, Modoni G, Galeano T, Guarino T, Foggetti I, Nisticò C, Giordano A, Pisconti S. Cafiero C, et al. Among authors: nisi c. Genes (Basel). 2025 Feb 24;16(3):265. doi: 10.3390/genes16030265. Genes (Basel). 2025. PMID: 40149417 Free PMC article.
Corrigendum: The molecular tumor board as a step in cancer patient management: a southern Italian experience.
Tommasi S, Maurmo L, Rizzo A, Carella C, Ranieri G, De Summa S, Mannavola F, Chiurì VE, Guida M, Nisi C, Montrone M, Giotta F, Patruno M, Lacalamita R, Pilato B, Zito FA, Fucci L, Coppola CA, Ditonno P, Nardulli P, Quaresmini D, Strippoli S. Tommasi S, et al. Among authors: nisi c. Front Med (Lausanne). 2024 Oct 25;11:1511339. doi: 10.3389/fmed.2024.1511339. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39526241 Free PMC article.
41 results